logo

ANVS

Annovis Bio·NYSE
--
--(--)
--
--(--)

ANVS fundamentals

Annovis Bio (ANVS) released its earnings on Aug 12, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.32 (YoY +27.27%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-0.32
+27.27%
Report date
Aug 12, 2025
EPS
Q2,2021
Q3,2021
Q1,2022
Q2,2022
Q3,2022
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
-0.34-0.35-0.72-1.07-0.93-1.63-2.26-0.72-0.44-0.97-0.43-0.32-0.32
Forecast
-0.37-0.44-0.65-0.855-1.0133-1.09-1.7756-0.8165-0.6279-0.6829-0.272-0.41-0.4025
Surprise
+8.11%
+20.45%
-10.77%
-25.15%
+8.22%
-49.54%
-27.28%
+11.82%
+29.93%
-42.04%
-58.09%
+21.95%
+20.50%
Revenue
Q2,2021
Q3,2021
Q1,2022
Q2,2022
Q3,2022
Q3,2023
Q4,2023
Q1,2024
Q2,2024
Q3,2024
Q4,2024
Q1,2025
Q2,2025
Actual
----------00000000
Forecast
----000--0000000
Surprise
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Earnings Call